MannKind Corporation Depreciation & Amortization | MNKD

Annual Depreciation & Amortization MannKind Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992
12.3 M	7.37 M	4.54 M	3.32 M	1.99 M	2.15 M	972 K	2.86 M	1.8 M	2.4 M	11 M	9.8 M	11.5 M	13 M	14.6 M	16.5 M	18.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.7 M	972 K	7.93 M

Quarterly Depreciation & Amortization MannKind Corporation

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.8 M	6.38 M	2.01 M	2.04 M	2.11 M	-	2.1 M	1.71 M	1.36 M	-	1.12 M	1.1 M	1.06 M	-	952 K	727 K	599 K	-	3 M	1.67 M	655 K	-	1.64 M	1.1 M	538 K	-	407 K	739 K	367 K	-	2.49 M	1.46 M	706 K	-	2.71 M	1.79 M	400 K	-	3.1 M	589 K	600 K	-	3.16 M	2.74 M	2.3 M	-	2.45 M	2.45 M	2.5 M	-	2.87 M	2.96 M	2.99 M	-	3.24 M	3.3 M	3.36 M	-	3.74 M	3.58 M	4.12 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
12.8 M	367 K	2.25 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Celsion Corporation CLSN	292 K	-	-6.63 %	$ 13.9 M	USA
Synthetic Biologics SYN	108 K	-	1.32 %	$ 16.2 M	USA
Dynavax Technologies Corporation DVAX	4.63 M	-	-	$ 2.02 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Qilian International Holding Group Limited QLI	1.46 M	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	2.07 M	-	1.35 %	$ 17.8 M	China
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Hepion Pharmaceuticals HEPA	30.8 K	-	-18.79 %	$ 39.3 K	USA
ARCA biopharma ABIO	83 K	-	1052.0 %	$ 415 M	USA
Codexis CDXS	5.25 M	$ 1.46	2.82 %	$ 127 M	USA
Ardelyx ARDX	3.06 M	$ 3.78	1.89 %	$ 911 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.9	1.01 %	$ 3.04 B	USA
Assembly Biosciences ASMB	129 K	$ 36.6	1.3 %	$ 410 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	4.7 M	-	-1.58 %	$ 28.1 M	China
Adial Pharmaceuticals ADIL	565	$ 7.12	6.91 %	$ 4.76 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Axsome Therapeutics AXSM	503 K	$ 206.68	0.16 %	$ 10.3 B	USA
GlycoMimetics GLYC	84 K	-	9357.83 %	$ 1.01 B	USA
AnaptysBio ANAB	559 K	$ 56.8	0.94 %	$ 1.63 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AVROBIO AVRO	1.38 M	-	1083.1 %	$ 745 M	USA
BioMarin Pharmaceutical BMRN	79.6 M	$ 66.53	0.15 %	$ 12.8 B	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Bicycle Therapeutics plc BCYC	6.42 M	$ 4.3	1.42 %	$ 298 M	Britain
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
ChromaDex Corporation CDXC	612 K	-	-0.88 %	$ 598 M	USA